334 related articles for article (PubMed ID: 33143616)
1. Potential Therapeutic Targets of Curcumin, Most Abundant Active Compound of Turmeric Spice: Role in the Management of Various Types of Cancer.
Almatroodi SA; Syed MA; Rahmani AH
Recent Pat Anticancer Drug Discov; 2021; 16(1):3-29. PubMed ID: 33143616
[TBL] [Abstract][Full Text] [Related]
2. Multitargeting by turmeric, the golden spice: From kitchen to clinic.
Gupta SC; Sung B; Kim JH; Prasad S; Li S; Aggarwal BB
Mol Nutr Food Res; 2013 Sep; 57(9):1510-28. PubMed ID: 22887802
[TBL] [Abstract][Full Text] [Related]
3. The golden spice curcumin in cancer: A perspective on finalized clinical trials during the last 10 years.
Karaboga Arslan AK; Uzunhisarcıklı E; Yerer MB; Bishayee A
J Cancer Res Ther; 2022; 18(1):19-26. PubMed ID: 35381757
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of curcumin action: signal transduction.
Shehzad A; Lee YS
Biofactors; 2013; 39(1):27-36. PubMed ID: 23303697
[TBL] [Abstract][Full Text] [Related]
5. Modulation of apoptosis-related cell signalling pathways by curcumin as a strategy to inhibit tumor progression.
Chen J; Wang FL; Chen WD
Mol Biol Rep; 2014 Jul; 41(7):4583-94. PubMed ID: 24604727
[TBL] [Abstract][Full Text] [Related]
6. The use of curcumin as an effective adjuvant to cancer therapy: A short review.
Bashang H; Tamma S
Biotechnol Appl Biochem; 2020 Mar; 67(2):171-179. PubMed ID: 31608504
[TBL] [Abstract][Full Text] [Related]
7. Traditional Uses, Therapeutic Effects and Recent Advances of Curcumin: A Mini-Review.
Slika L; Patra D
Mini Rev Med Chem; 2020; 20(12):1072-1082. PubMed ID: 32286941
[TBL] [Abstract][Full Text] [Related]
8. Turmeric extract, with absorbable curcumin, has potent anti-metastatic effect in vitro and in vivo.
Li M; Yue GG; Tsui SK; Fung KP; Lau CB
Phytomedicine; 2018 Jul; 46():131-141. PubMed ID: 30097113
[TBL] [Abstract][Full Text] [Related]
9. Curcumin inhibits cancer progression through regulating expression of microRNAs.
Zhou S; Zhang S; Shen H; Chen W; Xu H; Chen X; Sun D; Zhong S; Zhao J; Tang J
Tumour Biol; 2017 Feb; 39(2):1010428317691680. PubMed ID: 28222667
[TBL] [Abstract][Full Text] [Related]
10. Molecular mechanisms underlying chemopreventive potential of curcumin: Current challenges and future perspectives.
Kumar G; Mittal S; Sak K; Tuli HS
Life Sci; 2016 Mar; 148():313-28. PubMed ID: 26876915
[TBL] [Abstract][Full Text] [Related]
11. Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases.
Kunnumakkara AB; Bordoloi D; Padmavathi G; Monisha J; Roy NK; Prasad S; Aggarwal BB
Br J Pharmacol; 2017 Jun; 174(11):1325-1348. PubMed ID: 27638428
[TBL] [Abstract][Full Text] [Related]
12. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells.
Reuter S; Eifes S; Dicato M; Aggarwal BB; Diederich M
Biochem Pharmacol; 2008 Dec; 76(11):1340-51. PubMed ID: 18755156
[TBL] [Abstract][Full Text] [Related]
13. A review of therapeutic potentials of turmeric (Curcuma longa) and its active constituent, curcumin, on inflammatory disorders, pain, and their related patents.
Razavi BM; Ghasemzadeh Rahbardar M; Hosseinzadeh H
Phytother Res; 2021 Dec; 35(12):6489-6513. PubMed ID: 34312922
[TBL] [Abstract][Full Text] [Related]
14. Anaphase-promoting complex/cyclosome protein Cdc27 is a target for curcumin-induced cell cycle arrest and apoptosis.
Lee SJ; Langhans SA
BMC Cancer; 2012 Jan; 12():44. PubMed ID: 22280307
[TBL] [Abstract][Full Text] [Related]
15. Curcuma as a functional food in the control of cancer and inflammation.
Schaffer M; Schaffer PM; Zidan J; Bar Sela G
Curr Opin Clin Nutr Metab Care; 2011 Nov; 14(6):588-97. PubMed ID: 21986478
[TBL] [Abstract][Full Text] [Related]
16. Latest in Vitro and in Vivo Assay, Clinical Trials and Patents in Cancer Treatment using Curcumin: A Literature Review.
Doello K; Ortiz R; Alvarez PJ; Melguizo C; Cabeza L; Prados J
Nutr Cancer; 2018; 70(4):569-578. PubMed ID: 29708445
[TBL] [Abstract][Full Text] [Related]
17. Curcumin mediates anticancer effects by modulating multiple cell signaling pathways.
Kunnumakkara AB; Bordoloi D; Harsha C; Banik K; Gupta SC; Aggarwal BB
Clin Sci (Lond); 2017 Aug; 131(15):1781-1799. PubMed ID: 28679846
[TBL] [Abstract][Full Text] [Related]
18. Induction of apoptosis by curcumin and its implications for cancer therapy.
Karunagaran D; Rashmi R; Kumar TR
Curr Cancer Drug Targets; 2005 Mar; 5(2):117-29. PubMed ID: 15810876
[TBL] [Abstract][Full Text] [Related]
19. Molecular targets of curcumin for cancer therapy: an updated review.
Kasi PD; Tamilselvam R; Skalicka-Woźniak K; Nabavi SF; Daglia M; Bishayee A; Pazoki-Toroudi H; Nabavi SM
Tumour Biol; 2016 Oct; 37(10):13017-13028. PubMed ID: 27468716
[TBL] [Abstract][Full Text] [Related]
20. Multifocal signal modulation therapy of cancer: ancient weapon, modern targets.
Das T; Sa G; Saha B; Das K
Mol Cell Biochem; 2010 Mar; 336(1-2):85-95. PubMed ID: 19826768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
